Status:
ACTIVE_NOT_RECRUITING
Minimal Clinically Important Difference of Clinical Test of Sensory Interaction on Balance in Individuals
Lead Sponsor:
Superior University
Conditions:
Stroke
Eligibility:
All Genders
18-85 years
Brief Summary
"Stroke is a major cause of disability worldwide, often leading to balance impairments due to deficits in sensory integration and motor control. These impairments hinder postural stability and functio...
Detailed Description
The objective of this study is to determine the Minimal Clinically Important Difference (MCID) for the Clinical Test of Sensory Interaction on Balance (CTSIB) in individuals with sub-acute stroke reha...
Eligibility Criteria
Inclusion
- Type of stroke Participants must have experienced a first unilateral hemispheric supratentorial stroke, which may be either ischemic or hemorrhagic in nature.
- Only individuals who have been clinically diagnosed with a stroke within the past 3 to 6 months will be included.
- Participants must have a Functional Ambulation Classification (FAC) score of 3, indicating independent ambulation with supervision or the use of a walking aid.
- The individual must have sufficient cognitive and communication abilities to understand and follow instructions during assessments.
- The study will include patients in the early subacute phase of stroke recovery, defined as 7 days to 3 months post-onset.
- Participants must have a Montreal Cognitive Assessment (MoCA) score of at least 24, indicating normal cognitive function or only mild cognitive impairment
Exclusion
- Individuals with severe cognitive impairments that prevent them from understanding, consenting to, or following simple instructions will be excluded.
- Participants with uncontrolled medical conditions such as cardiovascular disease or uncontrolled diabetes will not be eligible for the study.
- Individuals diagnosed with nerve compression conditions affecting motor or sensory function will be excluded.
- Patients exhibiting significant hemispatial neglect following a stroke will not be included in the study.
- Participants showing signs of unilateral spatial neglect, impacting their ability to process stimuli on one side, will be excluded.
- Patients who test positive for unilateral spatial neglect using the Catherine Line Bisection Test will be excluded.
- Individuals with severe visual impairments that compromise independent ambulation will not be eligible.
- Patients with gait disturbances due to conditions other than stroke (e.g., Parkinson's disease, severe arthritis) will be excluded.
- Individuals who are unable to comply with study protocols or behavioral requirements will not be included.
Key Trial Info
Start Date :
March 20 2025
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 20 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06905730
Start Date
March 20 2025
End Date
February 20 2026
Last Update
April 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Superior University
Lahore, Punjab Province, Pakistan